AGIO
Agios Pharm
NASDAQ: AGIO · HEALTHCARE · BIOTECHNOLOGY
$28.05
+13.10% today
Updated 2026-04-29
Market cap
$1.67B
P/E ratio
—
P/S ratio
30.88x
EPS (TTM)
$-7.26
Dividend yield
—
52W range
$22 – $46
Volume
1.1M
Agios Pharm (AGIO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+3.4%
Last 4 quarters
Revenue YoY growth
+86.1%
Most recent quarter
EPS YoY growth
-6.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.9%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-6.8%
2025-07-31
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-12 | $-1.85 | +5.1% | $27.71 | $27.96 | +0.9% |
| 2025-10-30 | $-1.78 | +6.8% | $41.96 | $43.24 | +3.1% |
| 2025-07-31 | $-1.93 | -10.3% | $37.54 | $35.00 | -6.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.95 | $-1.85 | +5.1% | $19.97M | +86.1% |
| 2025-09-30 | $-1.91 | $-1.78 | +6.8% | $12.88M | +43.7% |
| 2025-06-30 | $-1.75 | $-1.93 | -10.3% | $12.46M | +44.6% |
| 2025-03-31 | $-1.76 | $-1.55 | +11.9% | $8.73M | +6.6% |
| 2024-12-31 | $-1.63 | $-1.74 | -6.7% | $10.73M | +51.1% |
| 2024-09-30 | $7.91 | $-1.47 | -118.6% | $8.96M | +21.2% |
| 2024-06-30 | $-1.60 | $-1.69 | -5.6% | $8.62M | +28.4% |
| 2024-03-31 | $-1.65 | $-1.45 | +12.1% | $8.19M | — |
| 2023-12-31 | $-1.65 | $-1.72 | -4.2% | $7.10M | — |
| 2023-09-30 | $-1.70 | $-1.64 | +3.5% | $7.40M | — |
| 2023-06-30 | $-1.56 | $-1.51 | +3.2% | $6.71M | — |
| 2023-03-31 | $-1.70 | $-1.47 | +13.5% | — | — |
Frequently asked questions
Has Agios Pharm beaten earnings estimates?
Agios Pharm has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +3.4% over the last 4 quarters.
How does AGIO stock react to earnings?
AGIO stock has moved an average of -0.9% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is Agios Pharm's revenue growth rate?
Agios Pharm reported year-over-year revenue growth of +86.1% in its most recent quarter, with EPS growing -6.3% year-over-year.